Delavan Gary 4
4 · Goosehead Insurance, Inc. · Filed Apr 5, 2021
Insider Transaction Report
Form 4
Delavan Gary
VP of Corporate Sales
Transactions
- Sale
Class A Common Stock
2021-04-01$112.33/sh−205$23,027→ 0 total - Exercise/Conversion
Class A Common Stock
2021-04-01$10.00/sh+700$7,000→ 700 total - Sale
Class A Common Stock
2021-04-01$110.61/sh−71$7,853→ 482 total - Sale
Class A Common Stock
2021-04-01$111.61/sh−277$30,916→ 205 total - Sale
Class A Common Stock
2021-04-01$109.68/sh−147$16,123→ 553 total - Exercise/Conversion
Employee Stock Options (right to buy)
2021-04-01−700→ 53,600 totalExercise: $10.00Exp: 2028-04-26→ Class A Common Stock (700 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.04 to $110.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.06 to $111.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.08 to $112.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.10 to $112.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F5]One third (1/3rd) of the shares subject to the option shall vest and become exercisable, subject to continued employment, on each of the second, third and fourth anniversaries of the grant date; provided, that all shares subject to the option will vest and become exercisable if Mr. Delavan's employment is terminated without "cause" or for "good reason" (each as defined in either Mr. Delavan's option award agreement or the Issuer's Amended and Restated Omnibus Incentive Plan) within six month following a "change in control" (as defined in the Issuer's Amended and Restated Omnibus Incentive Plan).